A modern hospital room featuring advanced medical equipment with digital displays.
Keysi Estrada (Pexels) / Pexels License
Clinical Trials/September 25, 2026/3 min read

Recruiting Type 1 diabetes trials watch: what changed in the current registry feed

A plain-English watchlist of current recruiting Type 1 diabetes studies surfaced from ClinicalTrials.gov, with consent-first guardrails for families.

clinical trialsClinicalTrials.govT1Dtrial matching

What this is and is not

This is a discovery layer for official trial records. It is not an eligibility decision, treatment recommendation, or invitation to share private health information.

A useful trial watch should help a family ask better questions: Who is eligible? What is the intervention? Where is the site? What is the burden? What endpoints are being measured?

Recruiting records to inspect

  • A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes — RECRUITING, PHASE3. Interventions: VX-880, VX-017. Locations: Duarte, California, United States | San Francisco, California, United States | Miami, Florida, United States. This study will evaluate the safety, tolerabili...Source
  • The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action — RECRUITING, PHASE2. Interventions: Metformin. Locations: Indianapolis, Indiana, United States. Ovwerweight and obesity prevalence in persons with T1D has increased, which further complicates management and risk for comp...Source
  • Continuous Glucose Monitoring for Outpatient Diabetes Management After Hospital Discharge — RECRUITING, NA. Interventions: Libre 3 Plus Continuous Glucose Monitor, Dexcom G7 Continuous Glucose Monitor. Locations: Nashville, Tennessee, United States. This study aims to improve patient awareness of the utility o...Source
  • Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes — RECRUITING, PHASE1, PHASE2. Interventions: Allogenic Human Islet Cells, Gastrin 17. Locations: Duarte, California, United States. This clinical study will evaluate the safety and effectiveness of Gastrin treatment with...Source
  • Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes — RECRUITING, EARLY_PHASE1. Interventions: Study Visit 1, Placebo, Study Visit 2. Locations: Nashville, Tennessee, United States. This study aims to understand the heart and blood sugar health benefits of using an adjunct...Source
  • Fake Carbs Practice With AID System - MiniMed 780G in Children and Adolescents With T1D. — RECRUITING. Locations: Athens, Attica, Greece | Athens, Attica, Greece | Athens, Attica, Greece. Hybrid Closed Loop (HCL) systems, such as the MiniMed 780G, have significantly improved glycemic outcomes in Type 1 Diabet...Source
  • Semi-closed Loop Automated Insulin Therapy in the Pediatric Population Aged 2-6 Years With Type 1 Diabetes: Impact on Quality of Life and Glycemic Control — RECRUITING. Locations: Nice, France, France. The incidence of type 1 diabetes is increasing, with an incidence of +4% per year in France today. The treatment for type 1 diabetes is insulin therapy. In recent years, new...Source
  • Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes — RECRUITING, PHASE2. Interventions: parental training in behavior management, Lisdexamfetamine, Methylphenidate. Locations: Lodz, Łódź Voivodeship, Poland. This clinical trial aims to evaluate the safety and effectivenes...Source

Questions before contacting a study

  • Is the study specifically for Type 1 diabetes, and does it match the participant age, disease stage, and treatment context?
  • What travel, visit frequency, labs, devices, medication changes, and hypoglycemia risk are involved?
  • Can the family discuss the official record with their endocrinology team before sharing additional personal health details?

This article is an evidence-labeled information brief, not medical advice. Use the linked source records and your care team before making treatment decisions.